Pregnancy & MTCT
Pregnancy & HIV MTCT
Breast Milk Inhibits HIV and Prevents Oral Transmission in Mice
- Details
- Category: Pregnancy & HIV MTCT
- Published on Wednesday, 20 June 2012 00:00
- Written by Press Release
Human breast milk has a strong inhibitory effect on HIV in vitro and was shown to reduce the likelihood of oral transmission of the virus in a mouse model designed to mimic the human mouth and upper gastrointestinal tract, researchers reported in the June 14, 2012, edition of the open-access journal PLoS Pathogens.
WHO Recommends Continued Antiretroviral Treatment for HIV+ Women after Delivery
- Details
- Category: Women & HIV
- Published on Friday, 13 April 2012 00:00
- Written by Liz Highleyman
The World Health Organization (WHO) this month published new guidance recommending that women with HIV who receive combination antiretroviral therapy (ART) during pregnancy for prevention of mother-to-child transmission should remain on ART on an ongoing basis, regardless of CD4 T-cell count.
New U.K. HIV Guidelines Cover When to Start ART, Treatment as Prevention, Pregnancy
- Details
- Category: HIV Treatment Guidelines
- Published on Tuesday, 21 February 2012 00:00
- Written by Liz Highleyman
The British HIV Association (BHIVA) has issued revised guidelines for antiretroviral therapy (ART) for adults and for pregnant women and prevention of mother-to-child HIV prevention. Comments are currently being accepted.
CROI 2012: Infants with HIV Who Receive Early ART Can Safely Stop Treatment
- Details
- Category: HIV Disease Progression
- Published on Thursday, 22 March 2012 00:00
- Written by Press Release
HIV-infected infants who start antiretroviral therapy (ART) immediately after birth can interrupt treatment after 1-2 years and still do better than babies who delayed ART initiation until they developed symptoms, researchers reported at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this month in Seattle.
Antiretroviral Combos with Nevirapine Better Prevent Mother-to-Child HIV Transmission
- Details
- Category: Pregnancy & HIV MTCT
- Published on Monday, 06 February 2012 22:00
- Written by Press Release
Regimens containing 2 or 3 antiretroviral drugs, including nevirapine (Viramune), were more effective than zidovudine (AZT; Retrovir) monotherapy at preventing viral transmission to babies born to HV positive mothers who did not received treatment during pregnancy and delivery, according to a report in the June 21, 2012, New England Journal of Medicine.
More Articles...
- Nevirapine for 6 Months during Breast-feeding Prevents Perinatal HIV Transmission
- ICAAC 2011: Lopinavir/ritonavir Reduces Mother-to-Child HIV Transmission during Supplemental Breastfeeding
- DHHS Updates Perinatal Antiretroviral Treatment Guidelines
- Should Breastfeeding be an Option for HIV Positive Women in Developed Countries?
Web Design and Development by